Why are you looking at Emes2 Pharmaceuticals?
Email me when a Emes2 Pharmaceuticals recompete window opens.
Capability
Service linesALL OTHER SUPPORT SERVICES
Work mix: 100% prime · 0% sub · primary NAICS 562211 / PSC P100 SALVAGE- PREPARATION AND DISPOSAL OF EXCESS/SURPLUS PROPERTY
Where they win
3 agenciesRecompete exposure: Low · 1 in 24mo
Emes2 Pharmaceuticals has an estimated $118K in contracts returning to market over the next 24 months.
Agency buyer map
3 buyersRecompete exposure
LowEmes2 Pharmaceuticals has an estimated $118K in contracts returning to market over the next 24 months.
“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Emes2 Pharmaceuticals hold?
Emes2 Pharmaceuticals (UEI L9BAWRKDMLD4) shows $205K across 18 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Emes2 Pharmaceuticals have?
Emes2 Pharmaceuticals shows $205K across 18 award actions. SCOUT tracks 1 incumbent recompetes ($118K) returning to market in the next 24 months.
Which agencies does Emes2 Pharmaceuticals work with?
Emes2 Pharmaceuticals’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (67%), Department of Veterans Affairs (VA) (23%), Department of Justice (DOJ) (11%).
What is the UEI for Emes2 Pharmaceuticals?
The Unique Entity ID (UEI) for Emes2 Pharmaceuticals is L9BAWRKDMLD4.
Does Emes2 Pharmaceuticals have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Emes2 Pharmaceuticals, — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.